G1 Therapeutics to Participate in Two Upcoming Conferences

Rhea-AI Summary

On November 10, 2021, G1 Therapeutics (GTHX) announced participation in two virtual investor conferences. CEO Jack Bailey will present on November 17 at 8:00 AM EST at the Stifel 2021 Virtual Healthcare Conference. Additionally, he will engage in a fireside chat on December 1 at 12:35 PM EST during the 4th Annual Evercore ISI HealthCONx Conference. Both events will be webstreamed, accessible through the company's website. G1 Therapeutics focuses on developing cancer therapies, including its commercial product COSELA™.

RESEARCH TRIANGLE PARK, N.C., Nov. 10, 2021 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that the Company will participate in two upcoming virtual investor conferences.

• On November 17, 2021 at 8:00 AM EST, G1’s Chief Executive Officer Jack Bailey will present at the Stifel 2021 Virtual Healthcare Conference.
  
  
• On December 1, 2021 at 12:35 PM EST, Mr. Bailey will participate in a fireside chat at the 4th Annual Evercore ISI HealthCONx Conference.
  

The webcast of both events will be accessible on the Events & Presentations page of http://www.g1therapeutics.com.

About G1 Therapeutics
G1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of next generation therapies that improve the lives of those affected by cancer, including the Company’s first commercial product, COSELA™ (trilaciclib). G1 has a deep clinical pipeline and is executing a tumor-agnostic development plan evaluating trilaciclib in a variety of solid tumors, including colorectal, breast, lung, and bladder cancers. G1 Therapeutics is based in Research Triangle Park, N.C. For additional information, please visit www.g1therapeutics.com and follow us on Twitter @G1Therapeutics.

Contacts:
Will Roberts
Vice President, Investor Relations & Corporate Communications
919-907-1944
wroberts@g1therapeutics.com

FAQ

What events is G1 Therapeutics (GTHX) participating in November 2021?

G1 Therapeutics will present at the Stifel 2021 Virtual Healthcare Conference on November 17, 2021, at 8:00 AM EST.

When is the G1 Therapeutics fireside chat scheduled?

The fireside chat with G1 Therapeutics CEO Jack Bailey is scheduled for December 1, 2021, at 12:35 PM EST.

How can I access the G1 Therapeutics (GTHX) conference webcasts?

The webcasts for G1 Therapeutics' events can be accessed through the Events & Presentations page on their website.

What is G1 Therapeutics known for?

G1 Therapeutics is known for developing next-generation therapies for cancer, including its first commercial product, COSELA™.